CHEMOMAB THERAPEUTICS LTD (CMMB) Stock Price & Overview
NASDAQ:CMMB • US16385C2035
The current stock price of CMMB is 1.88 USD. Today CMMB is up by 2.73%. In the past month the price increased by 29.66%. In the past year, price decreased by -62.4%.
CMMB Key Statistics
- Market Cap
- 35.45M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.76
- Dividend Yield
- N/A
CMMB Stock Performance
CMMB Stock Chart
CMMB Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to CMMB. When comparing the yearly performance of all stocks, CMMB is a bad performer in the overall market: 93.12% of all stocks are doing better.
CMMB Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CMMB. CMMB has a great financial health rating, but its profitability evaluates not so good.
CMMB Earnings
CMMB Forecast & Estimates
8 analysts have analysed CMMB and the average price target is 17.85 USD. This implies a price increase of 849.47% is expected in the next year compared to the current price of 1.88.
CMMB Groups
Sector & Classification
CMMB Financial Highlights
Over the last trailing twelve months CMMB reported a non-GAAP Earnings per Share(EPS) of -2.76. The EPS increased by 61.42% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -106.24% | ||
| ROE | -121.9% | ||
| Debt/Equity | 0 |
CMMB Ownership
CMMB Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.51 | 406.874B | ||
| AMGN | AMGEN INC | 16.19 | 199.203B | ||
| GILD | GILEAD SCIENCES INC | 16.28 | 178.678B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.56 | 116.013B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.25 | 80.332B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.98 | 42.526B | ||
| INSM | INSMED INC | N/A | 30.205B | ||
| NTRA | NATERA INC | N/A | 28.081B | ||
| BIIB | BIOGEN INC | 11.5 | 27.132B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.01 | 20.958B | ||
| MRNA | MODERNA INC | N/A | 20.742B | ||
| EXAS | EXACT SCIENCES CORP | 340.51 | 19.757B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.5B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CMMB
Company Profile
Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The firm specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.
Company Info
CHEMOMAB THERAPEUTICS LTD
Kiryat Atidim, Building 7
TEL AVIV-YAFO 02139 IL
CEO: Neil Cohen
Employees: 20
Phone: 972773310156
CHEMOMAB THERAPEUTICS LTD / CMMB FAQ
Can you describe the business of CHEMOMAB THERAPEUTICS LTD?
Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The firm specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.
What is the current price of CMMB stock?
The current stock price of CMMB is 1.88 USD. The price increased by 2.73% in the last trading session.
Does CMMB stock pay dividends?
CMMB does not pay a dividend.
What is the ChartMill technical and fundamental rating of CMMB stock?
CMMB has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the sector and industry classification for CHEMOMAB THERAPEUTICS LTD?
CHEMOMAB THERAPEUTICS LTD (CMMB) operates in the Health Care sector and the Biotechnology industry.
What is CHEMOMAB THERAPEUTICS LTD worth?
CHEMOMAB THERAPEUTICS LTD (CMMB) has a market capitalization of 35.45M USD. This makes CMMB a Nano Cap stock.
Can you provide the short interest for CMMB stock?
The outstanding short interest for CHEMOMAB THERAPEUTICS LTD (CMMB) is 2.56% of its float.